Pietzner, Maik http://orcid.org/0000-0003-3437-9963
Chua, Robert Lorenz
Wheeler, Eleanor http://orcid.org/0000-0002-8616-6444
Jechow, Katharina
Willett, Julian D. S.
Radbruch, Helena http://orcid.org/0000-0001-6941-3397
Trump, Saskia
Heidecker, Bettina
Zeberg, Hugo http://orcid.org/0000-0001-7118-1249
Heppner, Frank L. http://orcid.org/0000-0001-9816-8917
Eils, Roland
Mall, Marcus A. http://orcid.org/0000-0002-4057-2199
Richards, J. Brent http://orcid.org/0000-0002-3746-9086
Sander, Leif-Erik http://orcid.org/0000-0002-0476-9947
Lehmann, Irina
Lukassen, Sören http://orcid.org/0000-0001-7045-6327
Wareham, Nicholas J. http://orcid.org/0000-0003-1422-2993
Conrad, Christian http://orcid.org/0000-0001-7036-342X
Langenberg, Claudia http://orcid.org/0000-0002-5017-7344
Article History
Received: 10 January 2022
Accepted: 12 July 2022
First Online: 15 August 2022
Competing interests
: E.W. is now an employee of AstraZeneca. J.B.R.’s institution has received investigator-initiated grant funding from Eli Lilly, GlaxoSmithKline and Biogen for projects unrelated to this research. He is the CEO of 5 Prime Sciences (ExternalRef removed), which provides research services for biotech, pharma and venture capital companies for projects unrelated to this research. The remaining authors declare no competing interests.